[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6767 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
                                H. R. 6767

 To amend the Public Health Service Act to include Middle Eastern and 
   North African (MENA) individuals in the statutory definition of a 
``racial and ethnic minority group'', to direct the Secretary of Health 
and Human Services to conduct a comprehensive study of MENA population 
                    health, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           December 16, 2025

   Ms. Tlaib (for herself, Mrs. Dingell, Ms. Kelly of Illinois, Ms. 
   Stansbury, Ms. Barragan, Mr. Carson, Ms. Clarke of New York, Mr. 
 Correa, Mr. Garcia of Illinois, Mr. Goldman of New York, Ms. Norton, 
  Mr. Johnson of Georgia, Ms. Lee of Pennsylvania, Ms. McCollum, Ms. 
 Ocasio-Cortez, Ms. Pou, Ms. Schakowsky, and Ms. Simon) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
 To amend the Public Health Service Act to include Middle Eastern and 
   North African (MENA) individuals in the statutory definition of a 
``racial and ethnic minority group'', to direct the Secretary of Health 
and Human Services to conduct a comprehensive study of MENA population 
                    health, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Health Equity and Middle Eastern and 
North African Community Inclusion Act of 2025'' or the ``Health Equity 
and MENA Community Inclusion Act of 2025''.

SEC. 2. DEFINITION.

    In this Act, the terms ``Middle Eastern and North African'' or 
``MENA'', with respect to individuals or populations, includes 
individuals or populations who identify with or belong to one or more 
nationalities or ethnic groups originating in a country (or portion 
thereof) in the Middle Eastern and North African region (such as 
Lebanese, Iranians, Egyptians, Moroccans, Yemenis, Chaldeans, 
Imazighen, Kurds, Palestinians, and Yazidis).

SEC. 3. FINDINGS.

    Congress finds the following:
            (1) On March 28, 2024, the Office of Management and Budget 
        formally recognized Middle Eastern and North African 
        populations in Statistical Policy Directive Number 15 (in this 
        section referred to as ``SPD 15''), which established, since 
        its issuance in 1977, the minimum standards for the collection, 
        management, and presentation of data on race and ethnicity.
            (2) In 1985, the Secretary of Health and Human Services 
        produced a ``Report on Black and Minority Health'', which 
        analyzed persistent health differences between the general 
        population and the non-White populations recognized in SPD 15 
        and served as the basis for the foundation of the Office of 
        Minority Health (in this section referred to as the ``OMH'').
            (3) Through the establishment of the OMH in 1986, the 
        Secretary of Health and Human Services has developed health 
        policies and programs that eliminate health disparities and 
        improve the health of racial and ethnic minority populations.
            (4) Congress has funded the OMH to ensure improved health 
        status of racial and ethnic minorities, and to develop measures 
        to evaluate the effectiveness of activities aimed at reducing 
        health disparities and supporting the local community. The 
        activities of the OMH have addressed health disparities, 
        including with respect to physical activity and nutrition, 
        clinical conditions, individual social needs, and the social 
        determinants of health for ``racial and ethnic minority 
        groups''.
            (5) Before the amendments made by this Act, section 
        1707(g)(1) of the Public Health Service Act (42 U.S.C. 300u-
        6(g)(1)) defined the term ``racial and ethnic minority group'' 
        (for whom the OMH works to improve health outcomes and 
        eliminate health disparities) to exclude Middle Easterners and 
        North Africans, and thereby prevented MENA populations from 
        accessing critical resources intended to assist historically 
        marginalized communities.
            (6) Independent researchers and private sector research 
        initiatives have found significant health disparities between 
        MENA individuals and the non-Hispanic White population, as well 
        as significant overlap between the health outcomes and health 
        conditions of MENA individuals and those of other racial and 
        ethnic minority groups.
            (7) Poor health outcomes are often connected to 
        impoverishment in other aspects of life and are exacerbated by 
        additional barriers to access high-quality health coverage, 
        whether in terms of language, eligibility, health literacy, or 
        discrimination at the point-of-service.
            (8) A recent study published in the journal, Proceedings of 
        the National Academy of Sciences, suggested that MENA 
        individuals are not perceived as White and do not perceive 
        themselves as White.
            (9) Research on the health outcomes and health conditions 
        of MENA individuals is troubling and suggests that efforts must 
        be made on the Federal level to disaggregate the demographic 
        data of MENA individuals from the demographic data of 
        individuals in the non-Hispanic White category and fully 
        understand the social determinants of health for health 
        disparities and outcomes experienced by MENA individuals.
            (10) MENA individuals are not included among the groups for 
        whom the OMH works to improve health outcomes and eliminate 
        health disparities, which further limits the opportunity of 
        MENA individuals to access programs designed to address their 
        experiences and health conditions.
            (11) The OMH could better assess and eliminate health 
        disparities by conducting a comprehensive study of the health 
        of MENA individuals and recognizing MENA individuals as a 
        racial and ethnic minority group.

SEC. 4. INCLUSION OF MIDDLE EASTERNERS AND NORTH AFRICANS IN DEFINITION 
              OF RACIAL AND ETHNIC MINORITY GROUPS.

    (a) In General.--Section 1707(g)(1) of the Public Health Service 
Act (42 U.S.C. 300u-6(g)(1)) is amended by striking ``Blacks; and 
Hispanics'' and inserting ``Blacks or African Americans; Hispanics; and 
Middle Easterners and North Africans''.
    (b) Sense of Congress.--It is the sense of Congress that subsection 
(a) should be implemented so as to ensure that--
            (1) the definition of a ``racial and ethnic minority 
        group'' in section 1707(g)(1) of the Public Health Service Act 
        (42 U.S.C. 300u-6(g)(1)), as amended by subsection (a), is 
        applied in the implementation and execution of Federal programs 
        and activities that reference such definition; and
            (2) no racial or ethnic minority group served by such 
        programs and activities is negatively impacted by the amendment 
        made by subsection (a).
    (c) Undefined References.--Not later than 2 years after the date of 
enactment of this Act, the Secretary of Health and Human Services 
shall--
            (1) identify all regulations, guidance, orders, and 
        documents of the Department of Health and Human Services for 
        establishment or implementation of a health care or public 
        health program, activity, or survey that--
                    (A) use the term ``racial and ethnic minority 
                group'' or similar terminology; and
                    (B) do not define such term or terminology; and
            (2) take such actions as may be necessary to clarify 
        whether the definition of ``racial and ethnic minority group'' 
        in section 1707(g)(1) of the Public Health Service Act (42 
        U.S.C. 300u-6(g)(1)), as amended by subsection (a), applies to 
        such term or terminology.
    (d) Report to Congress.--Not later than 2 years after the date of 
enactment of this Act, the Secretary of Health and Human Services shall 
submit to Congress a report on the implementation of this section.

SEC. 5. REPORT ON HEALTH OF MIDDLE EASTERN AND NORTH AFRICAN 
              POPULATION.

    (a) Study Required.--The Secretary of Health and Human Services 
(referred to in this section as the ``Secretary'') shall conduct or 
support a comprehensive study regarding the unique health patterns and 
outcomes of MENA populations.
    (b) Requirements for Study.--The comprehensive study under 
subsection (a) shall include an enumeration of MENA populations across 
the United States, disaggregated by subpopulation, and with respect to 
each such population and subpopulation--
            (1) the rates of--
                    (A) health risk factors, including--
                            (i) behaviors, such as tobacco use, 
                        excessive alcohol consumption, physical 
                        inactivity, and unhealthy diet;
                            (ii) physiological factors, such as 
                        obesity, diabetes, high blood pressure, high 
                        blood sugar, and high cholesterol;
                            (iii) environmental factors, such as 
                        exposure to toxic chemicals, air and water 
                        pollution, and unsafe working conditions, 
                        including prevalence of work-related injuries;
                            (iv) genetic factors, such as family 
                        history of chronic diseases, presence of 
                        specific gene mutations, and racial and ethnic 
                        predisposition to certain conditions;
                            (v) demographic characteristics, such as 
                        age, geographic location, and English language 
                        proficiency; and
                            (vi) social determinants of health, such as 
                        household income, health insurance coverage, 
                        socioeconomic status, education level, housing 
                        instability, educational and employment 
                        opportunities, and access to culturally and 
                        linguistically appropriate service providers;
                    (B) prevalence of chronic disease or illness, 
                including--
                            (i) cancers, such as breast, lung, 
                        cervical, prostate, colorectal, liver, stomach, 
                        and oral cancer;
                            (ii) cardiovascular conditions, such as 
                        heart disease, atrial fibrillation, and stroke;
                            (iii) respiratory conditions, such as 
                        asthma, chronic obstructive pulmonary disease, 
                        and lung disease;
                            (iv) musculoskeletal conditions, such as 
                        osteoporosis and carpal tunnel syndrome;
                            (v) neurological conditions, such as 
                        Parkinson's disease, Alzheimer's and other 
                        related dementias, epilepsy, and cerebral 
                        palsy;
                            (vi) infectious diseases, such as HIV/AIDS, 
                        hepatitis B and C, and tuberculosis; and
                            (vii) autoimmune diseases, such as lupus, 
                        multiple sclerosis, ulcerative colitis, and 
                        rheumatoid arthritis;
                    (C) prevalence of disability and disorder, 
                including--
                            (i) vision impairments, such as blindness 
                        and low vision;
                            (ii) hearing conditions, such as deafness 
                        and varying degrees of hearing loss;
                            (iii) physical impairments, such as 
                        musculoskeletal conditions, amputation, 
                        paralysis, repetitive strain injuries, and 
                        other conditions that affect movement or 
                        require assistive devices;
                            (iv) intellectual or developmental 
                        conditions, such as Down syndrome, Prater-Willi 
                        syndrome, Angelman syndrome, autism, and 
                        attention-deficit/hyperactive disorder (ADHD), 
                        as well as other conditions that affect 
                        cognitive abilities, learning, and adaptive 
                        behaviors;
                            (v) mental or behavioral conditions, such 
                        as depression, anxiety, insomnia, sleep apnea, 
                        bipolar disorder, schizophrenia, and traumatic 
                        brain injury;
                            (vi) substance use disorders, such as 
                        disorders in use of alcohol, opioids, 
                        stimulants, and cannabis, and risk factors 
                        stemming from such disorders, such as liver 
                        damage and gastrointestinal issues;
                            (vii) genetic or blood disorders, such as 
                        sickle cell anemia, G6PD deficiency, 
                        hypertension, and thalassemia; and
                            (viii) endocrine disorders, such as 
                        diabetes, polycystic ovary syndrome (PCOS), and 
                        hypothyroidism;
                    (D) maternal and reproductive health outcomes, 
                including maternal morbidity and mortality, 
                infertility, and postpartum depression;
                    (E) nutritional health outcomes, including 
                malnutrition, vitamin D and iron deficiencies, among 
                other vitamin deficiencies;
                    (F) child and adolescent health outcomes, such as 
                pediatric developmental delays, childhood obesity, and 
                early-onset chronic conditions;
                    (G) dental and oral health outcomes, including 
                tooth loss, gum disease, and tooth decay;
                    (H) domestic violence, dating violence, sexual 
                assault, sexual harassment, and stalking; and
                    (I) morbidity and mortality, including the rates of 
                morbidity and mortality associated with the rates 
                referenced in subparagraphs (A) through (H);
            (2) analysis of--
                    (A) the factors and conditions that contribute most 
                to--
                            (i) the rates described in paragraph (1); 
                        and
                            (ii) the rates by which MENA subpopulations 
                        reported the outcomes referenced in 
                        subparagraphs (B) and (C) as a disease, 
                        illness, disorder, or disability;
                    (B) the leading causes of morbidity and mortality 
                and pregnancy-associated morbidity and mortality;
                    (C) the extent to which access to health care 
                facilities contributes to the associated outcomes of 
                care, including the rates described in paragraph (1); 
                and
                    (D) the disparities between MENA subpopulations and 
                between the aggregate MENA population and other racial 
                and ethnic populations in the rates described in 
                paragraph (1);
            (3) analysis, enumeration, or quantification of any other 
        health or health-related parameters the Secretary determines 
        necessary; and
            (4) analysis of the extent to which any or all of the 
        design, implementation, and evaluation of Federal health 
        programs contribute to the health factors, outcomes, and 
        conditions described in paragraphs (1) through (3).
    (c) Consultation.--The Secretary shall--
            (1) carry out this section in consultation, as appropriate, 
        with the Director of the Census Bureau, the Director of the 
        Centers for Disease Control and Prevention, the Director of the 
        National Institutes of Health, the Assistant Secretary for 
        Mental Health and Substance Use, and other stakeholders 
        (including community-based organizations); and
            (2) determine through such consultation the subpopulations 
        to be used for purposes of disaggregation of data pursuant to 
        subsection (b).
    (d) Online Portal.--Upon conclusion of the comprehensive study 
under this section, the Secretary shall establish a public online 
portal to catalogue the results of the study, its underlying data, and 
information in the report submitted pursuant to subsection (e)(2).
    (e) Reporting.--
            (1) Interim report.--Not later than 2 years after the date 
        of enactment of this Act, the Secretary shall submit to 
        Congress a report outlining the challenges associated with, and 
        progress toward implementing, health data collection for MENA 
        populations as a distinct category and the plan for completing 
        a comprehensive study regarding the unique health patterns and 
        outcomes of MENA populations.
            (2) Final report.--Not later than 30 days after the 
        conclusion of the comprehensive study under this section, and 
        not later than 2 years after the date of submission of the 
        interim report under paragraph (1), the Secretary shall submit 
        to Congress a report describing--
                    (A) the results of the study conducted under this 
                section; and
                    (B) the rulemakings and other actions the agencies 
                described in subsection (c)(1) can undertake to more 
                equitably include MENA individuals in their programs, 
                including whether and to what extent additional 
                resources are needed to increase rates of response 
                among MENA populations to Federal health surveys.
    (f) Privacy.--
            (1) In general.--In carrying out the comprehensive study 
        under this section, the Secretary shall implement robust 
        privacy protections to safeguard the personal data of the 
        individuals involved.
            (2) Minimum protections.--The privacy protections referred 
        to in paragraph (1) include the following:
                    (A) Personally identifiable information, such as 
                names or addresses, shall not be collected when 
                unnecessary for the purposes of the study.
                    (B) Any personally identifiable information that is 
                collected shall be securely destroyed upon completion 
                of the intended use of such information.
                    (C) All privacy protections and data handling 
                procedures shall be clearly communicated to any 
                individuals who may be subjects of the study, including 
                through informed consent if applicable.
            (3) Prohibition on inclusion of pii in online portal or 
        reports.--The Secretary shall not include any personally 
        identifiable information on the online portal under subsection 
        (d) or in the reports under subsection (e).
    (g) Violations.--Any person who, by virtue of an official position 
or affiliation with the Secretary--
            (1) has possession of, or access to, any record containing 
        individually identifiable information the disclosure of which 
        is prohibited by or under this section; and
            (2) knowingly discloses such a record to any person or 
        agency not entitled to receive the record,
shall be guilty of a misdemeanor and fined not more than $25,000.
    (h) Personally Identifiable Information Defined.--In this section, 
the term ``personally identifiable information'' means individually 
identifying information for or about an individual, including 
information likely to disclose the location or specific identity of a 
participating individual, regardless of whether the information is 
encoded, encrypted, hashed, or otherwise protected, including--
            (1) a first and last name;
            (2) a home or other physical address;
            (3) contact information (including a postal, email or 
        internet protocol address, or telephone or facsimile number);
            (4) a social security number, driver license number, 
        passport number, or student identification number; and
            (5) any other information, including date of birth, racial 
        or ethnic background, or religious affiliation, that would 
        serve to identify any individual.
    (i) Authorization of Appropriations.--There are authorized to be 
appropriated such sums as may be necessary to carry out this section.
                                 <all>